Reply to Pai

Clinical Infectious Diseases

Volumn 57, Issue 12, 2013, Pages 1786-

  Landersdorfer, Cornelia B ^a,b   Nation, Roger L ^a   Forrest, Alan ^b   Sandri, Ana M ^c   Zavascki, Alexandre P ^d   Li, Jian ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY AT BUFFALO   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMYXIN B;

ACCURACY; ALLOMETRY; AREA UNDER THE CURVE; BODY SIZE; BODY WEIGHT; DRUG DOSE REGIMEN; HUMAN; LEAN BODY WEIGHT; LETTER; MONTE CARLO METHOD; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; POLYMYXIN B;

EID: 84890030789     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit608     Document Type: Letter

References (3)

1. Pai MP. Polymyxin B dosing in obese and underweight adults. Clin Infect Dis 2013; 57: 1785
2. Sandri AM, Landersdorfer CB, Jacob J, et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: Implications for selection of dosage regimens. Clin Infect Dis 2013; 57:524-31
3. Janmahasatian S, Duffull SB, Ash S, Ward LC, ByrneNM,GreenB. Quantificationof leanbodyweight. Clin Pharmacokinet 2005; 44:1051-65